{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:01:22Z","timestamp":1788627682155,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a curative treatment for hematologic malignancies. Acute and chronic graft-versus-host disease (GvHD) are the major immune-mediated complications after alloHSCT. However, there is controversy whether neurologic complications after alloHSCT might represent manifestations of GvHD. We report three patients who acquired distinct, severe immune-mediated peripheral or central nervous system diseases after alloHSCT without other, concomitant GvHD manifestations. One patient had been diagnosed with B-cell chronic lymphocytic leukemia and two patients with high risk myelodysplastic syndrome. Patient #1 presented as LGI1- and GAD-IgG positive immune-mediated encephalitis, patient #2 was diagnosed with MOG-IgG positive encephalomyelitis, and patient #3 had chronic inflammatory polyneuropathy associated with SSA(Ro)-IgG positive Sj\u00f6gren\u2019s syndrome. 100% donor chimerism was detectable in the peripheral blood in all three. The specific antibodies were undetectable in donors\u2019 and patients\u2019 blood before alloHSCT suggesting that the antibodies had arisen from the transplanted donor immune system. Early intensive immunotherapy led to improvement of clinical symptoms and stability of the neurological disease, however, at the cost of losing the graft-versus-malignancy effect in one patient. In conclusion, we provide evidence of isolated, severe allo-immune diseases of the peripheral and central nervous system as complications of alloHSCT (\u201cneuro-GvHD\u201d). Interdisciplinary surveillance and thorough diagnostic work-up are needed for early diagnosis and treatment of neuro-immunologic complications after alloHSCT to improve the otherwise poor outcome.<\/jats:p>","DOI":"10.1038\/s41598-021-87989-z","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T10:04:56Z","timestamp":1618826696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Severe allo-immune antibody-associated peripheral and central nervous system diseases after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1038","volume":"11","author":[{"given":"Martin W.","family":"H\u00fcmmert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Hambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gingele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bredt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike P.","family":"Wattjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"G\u00f6hring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"M\u00f6hn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Trebst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Ganser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wegner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Skripuletz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"issue":"8","key":"87989_CR1","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1007\/s00415-019-09372-3","volume":"266","author":"I Sakellari","year":"2019","unstructured":"Sakellari, I. et al. Neurological adverse events post allogeneic hematopoietic cell transplantation: Major determinants of morbidity and mortality. J. Neurol. 266(8), 1960\u20131972 (2019).","journal-title":"J. Neurol."},{"issue":"10","key":"87989_CR2","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1002\/acn3.50909","volume":"6","author":"M Gavriilaki","year":"2019","unstructured":"Gavriilaki, M. et al. Neurologic complications after allogeneic transplantation: A meta-analysis. Ann. Clin. Transl. Neurol. 6(10), 2037\u20132047 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"87989_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.bbmt.2016.12.632","volume":"23","author":"E Maffini","year":"2017","unstructured":"Maffini, E. et al. Neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 23(3), 388\u2013397 (2017).","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"87989_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2141.2012.09070.x","volume":"157","author":"A Holbro","year":"2012","unstructured":"Holbro, A., Abinun, M. & Daikeler, T. Management of autoimmune diseases after haematopoietic stem cell transplantation. Br. J. Haematol. 157(3), 281\u2013290 (2012).","journal-title":"Br. J. Haematol."},{"issue":"6","key":"87989_CR5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/jnnp-2013-306657","volume":"85","author":"C Karam","year":"2014","unstructured":"Karam, C. et al. Immune-mediated neuropathies following stem cell transplantation. J. Neurol. Neurosurg. Psychiatry 85(6), 638\u2013642 (2014).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"87989_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11060-012-0962-9","volume":"110","author":"AM Delios","year":"2012","unstructured":"Delios, A. M., Rosenblum, M., Jakubowski, A. A. & DeAngelis, L. M. Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease. J. Neurooncol. 110(2), 251\u2013256 (2012).","journal-title":"J. Neurooncol."},{"issue":"8","key":"87989_CR7","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1212\/WNL.36.8.1087","volume":"36","author":"GB Bolger","year":"1986","unstructured":"Bolger, G. B. et al. Myasthenia gravis after allogeneic bone marrow transplantation: Relationship to chronic graft-versus-host disease. Neurology 36(8), 1087\u20131091 (1986).","journal-title":"Neurology"},{"issue":"2","key":"87989_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.hemonc.2017.04.001","volume":"12","author":"Y Tsutsumi","year":"2019","unstructured":"Tsutsumi, Y. et al. Myasthenia gravis after allogeneic bone marrow transplantation: A case report and literature review. Hematol. Oncol. Stem Cell Ther. 12(2), 110\u2013114 (2019).","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"87989_CR9","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3389\/fimmu.2019.01110","volume":"10","author":"MW Hummert","year":"2019","unstructured":"Hummert, M. W. et al. Investigation of oligoclonal IgG bands in tear fluid of multiple sclerosis patients. Front. Immunol. 10, 1110 (2019).","journal-title":"Front. Immunol."},{"issue":"1","key":"87989_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/08916930400022954","volume":"38","author":"F Franceschini","year":"2005","unstructured":"Franceschini, F. & Cavazzana, I. Anti-Ro\/SSA and La\/SSB antibodies. Autoimmunity 38(1), 55\u201363 (2005).","journal-title":"Autoimmunity"},{"key":"87989_CR11","first-page":"213","volume":"52","author":"E Stalberg","year":"1999","unstructured":"Stalberg, E. et al. Standards for quantification of EMG and neurography. The International Federation of Clinical Neurophysiology. Electroencephalogr. Clin. Neurophysiol. Suppl. 52, 213\u2013220 (1999).","journal-title":"Electroencephalogr. Clin. Neurophysiol. Suppl."},{"key":"87989_CR12","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3389\/fimmu.2019.01600","volume":"10","author":"T Seeliger","year":"2019","unstructured":"Seeliger, T. et al. Neuro-Sjogren: Peripheral neuropathy with limb weakness in Sjogren\u2019s Syndrome. Front. Immunol. 10, 1600 (2019).","journal-title":"Front. Immunol."},{"issue":"6","key":"87989_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/tid.12101","volume":"15","author":"S Borchers","year":"2013","unstructured":"Borchers, S. et al. Expansion of recipient-derived antiviral T cells may influence donor chimerism after allogeneic stem cell transplantation. Transpl. Infect. Dis. 15(6), 627\u2013633 (2013).","journal-title":"Transpl. Infect. Dis."},{"issue":"2","key":"87989_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk, D. M. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2), 177\u2013189 (2015).","journal-title":"Neurology"},{"issue":"7","key":"87989_CR15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00417-019-04301-6","volume":"257","author":"G Giannaccare","year":"2019","unstructured":"Giannaccare, G., Pellegrini, M., Bernabei, F., Scorcia, V. & Campos, E. Ocular surface system alterations in ocular graft-versus-host disease: All the pieces of the complex puzzle. Graefes Arch. Clin. Exp. Ophthalmol. 257(7), 1341\u20131351 (2019).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"87989_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski, C. H. et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren\u2019s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann. Rheum. Dis. 76(1), 9\u201316 (2017).","journal-title":"Ann. Rheum. Dis."},{"issue":"26","key":"87989_CR17","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1056\/NEJMra1703472","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser, R. & Blazar, B. R. Pathophysiology of chronic graft-versus-host disease and therapeutic targets. N. Engl. J. Med. 377(26), 2565\u20132579 (2017).","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"87989_CR18","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.bbmt.2014.08.010","volume":"20","author":"H Sousa","year":"2014","unstructured":"Sousa, H. et al. Cytomegalovirus infection in patients who underwent allogeneic hematopoietic stem cell transplantation in Portugal: A five-year retrospective review. Biol. Blood Marrow Transplant. 20(12), 1958\u20131967 (2014).","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"7","key":"87989_CR19","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.bbmt.2017.03.027","volume":"23","author":"J Ogonek","year":"2017","unstructured":"Ogonek, J. et al. Possible impact of cytomegalovirus-specific CD8(+) T cells on immune reconstitution and conversion to complete donor chimerism after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant. 23(7), 1046\u20131053 (2017).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"87989_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jneuroim.2018.08.003","volume":"323","author":"M Pirotte","year":"2018","unstructured":"Pirotte, M. et al. Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. J. Neuroimmunol. 323, 115\u2013118 (2018).","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"87989_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.braindev.2018.10.006","volume":"41","author":"K Nagai","year":"2019","unstructured":"Nagai, K., Maekawa, T., Terashima, H., Kubota, M. & Ishiguro, A. Severe anti-GAD antibody-associated encephalitis after stem cell transplantation. Brain Dev. 41(3), 301\u2013304 (2019).","journal-title":"Brain Dev."},{"issue":"9","key":"87989_CR22","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1708712","volume":"378","author":"J Dalmau","year":"2018","unstructured":"Dalmau, J. & Graus, F. Antibody-mediated encephalitis. N. Engl. J. Med. 378(9), 840\u2013851 (2018).","journal-title":"N. Engl. J. Med."},{"key":"87989_CR23","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/clinchem\/hvaa254","volume":"66","author":"A Budhram","year":"2020","unstructured":"Budhram, A. et al. Neural antibody testing in patients with suspected autoimmune encephalitis. Clin. Chem. 66, 1496\u20131509 (2020).","journal-title":"Clin. Chem."},{"issue":"3","key":"87989_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia, M. H. et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I The 2014 Diagnosis and Staging Working Group report. Biol. Blood Marrow Transplant. 21(3), 389-401 e381 (2015).","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"87989_CR25","first-page":"633","volume":"15","author":"H Openshaw","year":"1995","unstructured":"Openshaw, H., Slatkin, N. E., Parker, P. M. & Forman, S. J. Immune-mediated myelopathy after allogeneic marrow transplantation. Bone Marrow Transplant. 15(4), 633\u2013636 (1995).","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"87989_CR26","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1182\/blood.V91.7.2619","volume":"91","author":"J Ooi","year":"1998","unstructured":"Ooi, J. et al. Immune-mediated optic neuritis after unrelated allogeneic bone marrow transplantation. Blood 91(7), 2619 (1998).","journal-title":"Blood"},{"issue":"10","key":"87989_CR27","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/brain\/awq245","volume":"133","author":"O Grauer","year":"2010","unstructured":"Grauer, O. et al. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: Report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease. Brain 133(10), 2852\u20132865 (2010).","journal-title":"Brain"},{"issue":"4","key":"87989_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/ajcp\/89.4.543","volume":"89","author":"E Rouah","year":"1988","unstructured":"Rouah, E., Gruber, R., Shearer, W., Armstrong, D. & Hawkins, E. P. Graft-versus-host disease in the central nervous system. A real entity?. Am. J. Clin. Pathol. 89(4), 543\u2013546 (1988).","journal-title":"Am. J. Clin. Pathol."},{"key":"87989_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jneuroim.2017.04.005","volume":"307","author":"MI Stefanou","year":"2017","unstructured":"Stefanou, M. I. & Bischof, F. Central and peripheral nervous system immune-mediated demyelinating disease after allogeneic hematopoietic stem cell transplantation. J. Neuroimmunol. 307, 74\u201381 (2017).","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"87989_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.pediatrneurol.2014.07.007","volume":"52","author":"FM Baumer","year":"2015","unstructured":"Baumer, F. M., Kamihara, J. & Gorman, M. P. Neuromyelitis optica in an adolescent after bone marrow transplantation. Pediatr. Neurol. 52(1), 119\u2013124 (2015).","journal-title":"Pediatr. Neurol."},{"issue":"5","key":"87989_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.exphem.2006.01.011","volume":"34","author":"N Kroger","year":"2006","unstructured":"Kroger, N. et al. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma. Exp. Hematol. 34(5), 688\u2013694 (2006).","journal-title":"Exp. Hematol."},{"issue":"3","key":"87989_CR32","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1172\/JCI130272","volume":"130","author":"NR Mathew","year":"2020","unstructured":"Mathew, N. R. et al. Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia. J. Clin. Investig. 130(3), 1315\u20131329 (2020).","journal-title":"J. Clin. Investig."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87989-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87989-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87989-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T07:06:44Z","timestamp":1670051204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87989-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["87989"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-87989-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8527"}}